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Effluent Levels of Hyaluronic Acid Can Predict Ultimate Graft Outcome 
After Clinical Liver Transplantation: A Prospective Series 
O.L. Bronsther, P.N. Rao, A. Pinna, J. Snyder, S. Cowan, D. Kramer, S. Takaya, and T.E. Starzl 
PRIMARY nonfunction (PNF) of the liver is an inexact 
term and investigators continue to debate the site and 
origin of preservation injury. Some grafts with PNF fail in 
the operating room. while other grafts have to be replaced 
between I and 14 days postoperatively. The pathology of 
such grafts displays a spectrum of findings ranging from 
marked hepatocellular swelling and cholestasis to massive 
ischemic necrosis. Both recipient and donor etiological 
factors potentially contribute to PNF. Donor factors in-
clude the physiological condition of the heart-beating ca-
daver before organ procurement. the methods of preser-
vation. period of cold ischemia. and various reperfusion 
phenomena. To date. there has been no proven method to 
discriminate in advance of transplantation between clini-
cally acceptable and unacceptable liver allografts. 
Because the critical target of preservation injury has 
been increasingly perceived to be the hepatocyte mi-
crovasculature (HMV). U we attempted in this study to 
correlate hyaluronic acid (HA), an HMV-specific mark-' 
erKg-~ with ultimate graft outcome. 
Hyaluronic acid is a glycosoaminoglycan weighing 4 to 8 
million kd. It is synthesized in the cell plasma membrane. 
deposited in the extracellular matrix. transported by the 
lymphatics. and uniquely catabolized by the liver HMV. I-~ 
Serum HA has been used to monitor liver graft function/> 
and as a prognostic marker after Tylenol poisoning. 7 
Because HA is concentrated in HMV cells. the rationale 
for the present study was that preservation injury to these 
cells will result in the leakage of this substance into the 
organ effi!1ent. where it can be collected and assayed on 
the backtable before liver transplantation. 
I n a preliminary retrospective study. the feasibility was 
demonstrated of correlating effluent HA levels with graft 
function and viability in an accurate and reproducible 
manner. Effluent HA values of s400 I-Lg/L were associated 
with unequivocal early graft function. and grafts with HA 
values of >400 I-Lg/L were at high risk of developing PNF. ~ 
Therefore, we undertook the following prospective study. 
MATERIALS AND METHODS 
Seventy consecutive primary. crossmatch-negative. adult onho-
topic livers were transplanted into 70 adult recipients. Standard 
organ procurement techniques were used. All livers were pre-
,erved In University of WisconSin (UW) solution at 4°C. After 
variable periods of cold storage. 150 mL of cold Ringers lactate 
was flushed through the ponal vein. The suprahepatic cava was 
clamped and the effluent was collected through the mfrahepatic 
cava. These livers were then reftushed with 500 mL of cold UW 
solution. These perfusions were performed on the backtable while 
the livers were being prepared for implantation. All patients 
received I g of methylprednisolone in the operating room and 
Table 1. Graft Survival 
UneqUIVOCal Failure Failure From 
Group Cases (n) Graft SUMVal From PNF Other Causes 
HA ";400.0 58 55 0 3 
ILQiL (94.8%) 
HA >400.00 12 6 6 0 
I'QIL (50%) (50%) 
OverBlI9O-day graft survIVal = 87.10;. (61 of 70): overall incidence of PNF = 
8.6% (6 of 70). 
were then maintained on FK 506 and 20 mgld of methylprednis-
olone. Recipients were monitored daily for liver function. Ultra-
sounds. biopsies, and other invasive procedures were performed 
as clinically indicated. 
Assay \ 
The effluent was assayed for HA values using a radiometric assay 
marketed by Pharmacia Diagnostics.s All samples. including stan-
dards. were run in duplicate. Variation of results never exceeded 
2.2%. The assays can be performed in <3 hours. 
Statistical Analysis \ 
The Mann-Whitney U test. a nonparametric equivalent to the 
standard two-sample t test. was used to compare HA and liver 
function values between groups. 
Univariant logistic regression was used to predict PNF based 
on HA values. 
RESULTS 
Graft Survival 
Table I shows an overall90-day graft survival of87.1'/C (61 
of 70). PNF was only noted in livers with effluent HA 
Table 2. Donor Age and Cold Ischemia Time 
Group Cases (n) Donor Age (rangel CIT (range) 
HA s 400.0 58 343 !: 14.4 y" 14.7 !: 4.3 h" 
I'QIL E1~F ERK~OPKRF 
HA > 400.0 12 40.6 !: 1 1 .0 y" 14.2 !: 3.B h" 
!J.9IL (17-55) (102-210) 
·NS. 
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EFFLUENT LEVELS OF HYALURONIC ACID 
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Fig 1. Individual HA values and graft outcome. 
levels >400 /-LgiL. None 0\58 livers with low etHuent HA 
levels developed PNF. while 6 of 12 livers with high 
effluent HA levels developed PNF (P < .(05). Graft 
survival beyond 90 days was achieved in 55 of 58 livers 
with low etHuent HA values compared with 6 of 12 livers 
with high etHuent HA values (e < .(01). Three livers with 
low etHuent HA levels failed belween the 7th and 10th days 
postoperatively. These livers were lost to hepatic artery 
thrombosis in two cases and death from pneumonia in the 
third. 
Study Parameters 
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Table 4. Analysis of Fal .. PolltlYe Uverl 
Group Clinical Group AST(IU/L) AlT (lUlL) 
'5400.0 1287:t 1326 983 :!: 1041 
(n ~ 58) 
2 PNF 5137 :!: 4110 4046:!: 3545 
(n = 6) 
3 False-positive 4237:!: 2940 3502:!: 2230 
(n = 6) 
AST: group 1 \IS group 3. P < .003: group 1 vs group 2, P < .05: group 2 vs 
group 3. p: NS. 
AlT: group 1 vs group 3. P < .002: group 1 vs group 2. P < .05; group 2 \IS 
group 3, p: NS. 
cantly elevated in the group with high etHuent HA levels 
(>400 J.Lg/L) vs the group with low etHuent HA levels 
(:s400 J.Lg/L) (P < .006 and P < .0005) !Table 3). 
Indil'idual Effluent HA Lel'els and Graft Outcome. 
Mean HA values of successful grafts were 218.6 :t 16.2 
(mean:!: SE) J.LglL vs mean values for PNF grafts of 549.3 
::: 74.9 J.Lg/L (Fig I). All six grafts lost to -,PNF had 
significantly higher HA levels when compared with suc-
cessful grafts (P = .00(2). All PNF grafts had effluent HA 
values >400 J.LglL. 
Analysis of False-Positive Livers 
False positives were defined as livers that were success-
fully transplanted despite etHuent HA levels >400 J.LglL. 
However. these false-positive livers had a pattern of 
enzyme release similar to the six livers that experienced 
PNF (Table 4). 
1.0 -pc---..... IIR&::-------------, 
0.8 
Donor Age and Cold Ischemia Time. No significant O.S 
differences are noted in either variable between the two 
groups !Table 2). 
Peak Asparate Aminotransferase (AST) and Alanine 0.4 
Aminotransferase (AL TJ Levels After Orthotopic Lil'er 
Transpl(/ntation. Asparate aminotransferase and AL T 
values in the first 7 postoperative days were both signifi- 0.2 
Table 3. AST and AL T Levell After OL T 
Group AST (IUL) 
HA ,; 400.0 1287:!: 1326 
/-LgL (n ~ 57) 
HA :. 400.0 4687 :!: 3439 
~i (n = 12) 
P <.0006 
'W,lcoxon SIgn rank lest. 
ALT (lUL) 
983 :!: 1041 
(n = 57) 
3774 :!: 2438 
(n = 12) 
·0005 
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HA VALUES 
Fig 2. HA values analyzed as predictors of graft outcome using 
stepwise logistic regression. Analysis showed that an Increase of 
effluent HA values IS Significantly associated With an increase in 
the probability of PNF (improved chi-square of22.135; P ~ .0001). 
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Degree of Discrimination 
Logistic regression was used to test whether graft success 
and PNF was associated with effluent HA levels (Fig 2). 
Analysis showed that HA values were significantly asso-
ciated with both events (improved chi-square of 22.135, 
P = .00(1). This implies that an increase in effluent HA 
levels is associated with an increase in the probability of 
PNF. 
DISCUSSION AND CONCLUSIONS 
Six percent to 8% of transplanted livers never adequately 
function, with consequent death or retransplantation.9 
PNF is the leading cause of early graft loss and is respon-
sible for enormous morbidity, mortality, and expense. We 
believe that systematic measurements of HA effluent lev-
els will allow detection of livers that already have been 
seriously damaged and are at high risk of developing PNF. 
In this study. half the 12 livers failed from PNF in the 
high-risk group (HA >400 ~FK Conversely, livers with 
low HA values were uniformly suitable for transplantation, 
with no examples of PNF among 58 livers in the good risk 
group. 
Even though six livers with HA values >400 ~i 
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ultimately survived and were classified as false positives, 
these livers exhibited a severe injury pattern just short of 
catastrophic. The position of these livers on a risk scale 
can be seen with logistic regression analysis in Fig 2. If the 
HA value in future cases were known in advance. the use 
of these organs would be unwarranted. 
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